RxDoctor Payments DataLook up a doctor →

Amy Willingham, PA

Physician Assistant · Cape Girardeau, MONPI 1659649846

Payments from drug & device makers

$12,030in general payments, 2019–2025

Across 534 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • UCB, Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$913
  • Lilly USA, LLC$785
  • LEO Pharma Inc.$738
  • plus $5K from 23 others

What the payments were for

  • Food & beverage$11,14393%
  • Education$8877%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,030 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$345,177
Medicare patients
1,304
Services billed
6,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab33$124,853
Cosentyx Unoready PenSecukinumab17$123,499
RinvoqUpadacitinib13$97,033
Taltz AutoinjectorIxekizumab12$81,657
Dupixent SyringeDupilumab13$57,277
Fluorouracil102$8,206
Clobetasol Propionate147$7,173
Doxycycline Hyclate91$2,803
Triamcinolone Acetonide221$1,572
Ketoconazole94$1,158
Ammonium Lactate68$1,154
Metronidazole19$1,041
Minocycline Hcl31$825
Clindamycin Phosphate22$775
ValacyclovirValacyclovir Hcl32$773

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$2,239$97,03313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Cape Girardeau

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →